Department of Chemistry

portrait of Professor Christopher Abell FMedSci

Professor Christopher Abell FMedSci

Christ's College

Groups: Abell group website

Telephone: 01223 336405

E-mail: ca26@cam.ac.uk

One of the biggest challenges in biological chemistry is the design of small molecules that interact selectively with macromolecules. We are pioneering the development of the use of fragments to address this challenge. This approach involves close synergistic interaction between synthetic organic chemistry, biophysics and structural biology. We are using fragment-based methods to identify inhibitors of enzymes from Mycobacterium tuberculosis, and to develop small molecules that modulate protein-protein interactions. We are also keen to explore new applications for fragments e.g. to identify molecules that modulate the activity of riboswitches, and to assign function to orphan proteins.

Our second major area of research is to develop the use of microdroplets in microfluidics as a novel experimental platform for biological chemistry. This research is highly interdisciplinary and involves biological chemistry, microfluidics, nanofabrication, laser spectroscopy and mass spectrometry. We are particularly interested in looking at cells in droplets, e.g. bacteria to study quorum sensing, algae for bio-fuel development.

 

Publications

Investigating the specific interactions between carbonic anhydrase and a sulfonamide inhibitor by single-molecule force spectroscopy
SG Kamper, L Porter-Peden, R Blankespoor, K Sinniah, DJ Zhou, C Abell, T Rayment - Langmuir (2007) 23, 12561
(DOI: 10.1021/la702148v)
Fragment-based approaches to enzyme inhibition
A Ciulli, C Abell - Curr Opin Biotechnol (2007) 18, 489
(DOI: 10.1016/j.copbio.2007.09.003)
Coenzyme biosynthesis: Enzyme mechanism, structure and inhibition
DE Scott, A Ciulli, C Abell - Nat Prod Rep (2007) 24, 1009
(DOI: 10.1039/b703108b)
Surface-induced droplet fusion in microfluidic devices
LM Fidalgo, C Abell, WTS Huck - Lab on a Chip - Miniaturisation for Chemistry and Biology (2007) 7, 984
(DOI: 10.1039/b708091c)
Rational design, synthesis, and evaluation of nanomolar type II dehydroquinase inhibitors
RJ Payne, F Peyrot, O Kerbarh, AD Abell, C Abell - ChemMedChem (2007) 2, 1015
(DOI: 10.1002/cmdc.200700032)
Fragment-based approaches to inhibitor discovery: targeting cofactor-binding sites and protein-protein interactions
A Ciulli, TL Blundell, C Abell - DRUG FUTURE (2007) 32, 13
Design, synthesis, and structural studies on potent biaryl inhibitors of type II dehydroquinases
RJ Payne, A Riboldi-Tunnicliffe, O Kerbarh, AD Abell, AJ Lapthorn, C Abell - ChemMedChem (2007) 2, 1010
(DOI: 10.1002/cmdc.200700062)
Nucleophile selectivity of chorismate-utilizing enzymes
O Kerbarh, A Ciulli, DY Chirgadze, TL Blundell, C Abell - Chembiochem (2007) 8, 622
(DOI: 10.1002/cbic.200700019)
Quantitative detection of protein expression in single cells using droplet microfluidics
A Huebner, M Srisa-Art, D Holt, C Abell, F Hollfelder, AJ Demello, JB Edel - Chemical Communications (2007), 1218
(DOI: 10.1039/b618570c)
Crystal structure of Escherichia coli ketopantoate reductase in a ternary complex with NADP(+) and pantoate bound - Substrate recognition, conformational change, and cooperativity
A Ciulli, DY Chirgadze, AG Smith, TL Blundell, C Abell - J Biol Chem (2007) 282, 8487
(DOI: 10.1074/jbc.M611171200)

 


General


Research Interests


Teaching


Personal


Publications

Funding


Funding: 

Further Funding Information: 

CV

CV: